Alexander Willemse, PhD, MSc
Chief Executive Officer
Joins BioConnection from 2008
Before joining BioConnection, Alexander worked for several (pharmaceutical) companies. He started his career at Organon NV in 1998 and moved to OctoPlus in 2003 as managing director of Octoplus Development BV (OPD). Since 2008 he is the CEO of BioConnection BV.
He studied chemical engineering at the Delft University of Technology where he also obtained his PhD.
He gave a lot of courses such as “particle size measurement for aerosol systems” at the University of California (UCLA) and “Measuring techniques for biophysical systems” at the University of Leuven. Belgium. For the Top Institute Pharma in the Netherlands he contributed to the course “Drug Development Simulation” as CMC expert in 2007, 2008 and 2009. He is the (co)-author of more than 20 scientific publications.
“As CEO I am entirely responsible for BioConnection. The work is very divers and challenging. Our main aim is to give our costumers the best products and services as we can. BioConnection is your excellent choice for Fill & Finish of clinical, small and large-scale batches, because of our state-of-the-art cGMP facilities and our experience in developing and manufacturing of bio-pharmaceutical products.
We offer a broad range of support services for all stages and aspects of biopharmaceuticals (CMC) development ranging from formulation development, process development, analytical development, stability studies, scale-up and packaging of final products to support clinical trials and commercial activities. So, with BioConnection you are in good hands, saving a great deal of time and money”.